Stockscreener 앱 받기
0.9007
7.17%
-0.0696
시간 외 거래:
.90
-0.0007
-0.08%
전일 마감가:
$0.9703
열려 있는:
$0.9554
하루 거래량:
226.59K
Relative Volume:
0.82
시가총액:
$23.68M
수익:
$338.00K
순이익/손실:
$-47.58M
주가수익비율:
-0.2699
EPS:
-3.3374
순현금흐름:
$-50.28M
1주 성능:
-9.50%
1개월 성능:
+1.20%
6개월 성능:
-33.28%
1년 성능:
-75.12%
1일 변동 폭
$0.86
$0.971
1주일 범위
$0.86
$0.995
52주 변동 폭
$0.797
$5.10
센티 바이오사이언시스 Stock (SNTI) Company Profile
명칭
Senti Biosciences Inc
전화
(650) 239-2030
주소
2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO
Compare SNTI vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNTI
Senti Biosciences Inc
|
0.9007 | 25.51M | 338.00K | -47.58M | -50.28M | -3.3374 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
센티 바이오사이언시스 Stock (SNTI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-14 | 개시 | H.C. Wainwright | Buy |
| 2025-06-06 | 개시 | Laidlaw | Buy |
| 2022-10-07 | 개시 | Morgan Stanley | Equal-Weight |
센티 바이오사이언시스 주식(SNTI)의 최신 뉴스
Senti Biosciences Amends Lease, Restructures GeneFab Sublease - TipRanks
Senti Biosciences (NASDAQ: SNTI) halves Alameda space and resets lease with GeneFab - Stock Titan
Gains Report: Is Senti Biosciences Inc stock good for income investors2026 Volume Leaders & High Yield Equity Trading Tips - baoquankhu1.vn
Macro Review: Does Senti Biosciences Inc have a sustainable dividendQuarterly Growth Report & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Should I trade or invest in Senti Biosciences Inc2026 Pullback Review & High Yield Equity Trading Tips - baoquankhu1.vn
Senti Biosciences (SNTI) Stock Analysis Report | Financials & Insights - Benzinga España
Senti Biosciences Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView
Senti Biosciences (SNTI) officer has 10,757 shares withheld for taxes - Stock Titan
Senti Biosciences (SNTI) CEO reports 80,666-share tax withholding on RSUs - Stock Titan
SNTI Stock Price, Quote & Chart | SENTI BIOSCIENCES INC (NASDAQ:SNTI) - ChartMill
Senti Biosciences Inc (SNTI) DEC/2025 Earning Prediction - Intellectia AI
Is Senti Biosciences Inc. stock a buy before product launchesWeekly Risk Report & Low Volatility Stock Recommendations - Naître et grandir
Risk Off: Is Senti Biosciences Inc stock good for income investorsJuly 2025 Levels & Growth Focused Stock Reports - baoquankhu1.vn
Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference - Bitget
Miami healthcare conference talk from Senti Bio CEO will be webcast live - Stock Titan
SNTI PE Ratio & Valuation, Is SNTI Overvalued - Intellectia AI
Senti Biosciences, Inc. (NASDAQ:SNTI) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Senti Bio joins Cell & Gene Live cell therapy webinar - National Today
SNTI Should I Buy - Intellectia AI
Senti Biosciences (NASDAQ:SNTI) Shares Up 1.6% – Should You Buy? - Defense World
Senti Bio Participates in Cell & Gene Live Event on Innovative Therapies - Intellectia AI
Senti Biosciences to Showcase Gene Circuit Technology and Partnership Opportunities at TD Cowen Health Care Conference - Quiver Quantitative
Senti Bio CEO to highlight gene circuit pipeline at TD Cowen conference - Stock Titan
Senti Biosciences: A Waiting Game for Investors () - aktiencheck.de
Can Senti Biosciences Inc. sustain its profitability2025 Big Picture & Weekly High Return Stock Opportunities - mfd.ru
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development - The Manila Times
How a cell therapy event spotlighted Senti Bio’s ‘logic-gated’ treatments - Stock Titan
Senti Biosciences reports promising phase 1 trial results - MSN
Will Senti Biosciences Inc. be affected by tariffsJuly 2025 Sector Moves & Verified Momentum Watchlists - mfd.ru
Senti Biosciences Inc. (SNTI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Insider Trends: What are the analyst revisions for Senti Biosciences IncIs ICON stock a good investment in YEARJuly 2025 Spike Watch & Accurate Trade Setup Notifications - baoquankhu1.vn
Published on: 2026-02-16 00:06:47 - mfd.ru
Can Senti Biosciences Inc. deliver alphaTrade Signal Summary & Daily Entry Point Trade Alerts - mfd.ru
Senti Biosciences completes enrollment in Phase 1 clinical trial of Senti-202 - marketscreener.com
Senti Biosciences Completes Enrollment In Phase 1 Clinical Trial Of Senti-202 - TradingView
Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) - The Manila Times
Leukemia cell therapy SENTI-202 heads for FDA talks after early remissions - Stock Titan
Does Senti Biosciences Inc. have a sustainable dividendShare Buyback & Smart Allocation Stock Tips - mfd.ru
Retail Surge: Is FONR benefiting from interest rate changesIPO Watch & Weekly Sector Rotation Insights - baoquankhu1.vn
Gains Recap: Does Senti Biosciences Inc have a sustainable dividendMarket Trend Summary & AI Driven Price Forecasts - baoquankhu1.vn
Aug Mood: Should I trade or invest in Senti Biosciences IncInsider Selling & AI Forecast Swing Trade Picks - baoquankhu1.vn
Growth Value: What are the analyst revisions for Senti Biosciences IncIs ICON stock a good investment in YEAR2025 Top Decliners & Accurate Technical Buy Alerts - baoquankhu1.vn
Aug Movers: Does Senti Biosciences Inc have a sustainable dividend2025 Winners & Losers & Verified Momentum Stock Alerts - baoquankhu1.vn
Senti Biosciences, Inc. (NASDAQ:SNTI) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026 - The Manila Times
Inside Senti Bio’s 8-minute gene circuit pitch at Taipei’s 2026 healthcare conference - Stock Titan
Insider Buy: Is Senti Biosciences Inc stock good for income investorsJuly 2025 Update & Growth Oriented Trading Recommendations - baoquankhu1.vn
US Market Recap: Will EQT Corporation stock go up in YEARPortfolio Value Report & Real-Time Buy Signal Alerts - baoquankhu1.vn
Can Senti Biosciences Inc sustain its profitability2025 Year in Review & Verified Momentum Stock Ideas - baoquankhu1.vn
Market Rankings: Is Senti Biosciences Inc benefiting from innovation trendsJuly 2025 Outlook & Technical Entry and Exit Tips - baoquankhu1.vn
Block Trades: Is Senti Biosciences Inc benefiting from innovation trendsInflation Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
센티 바이오사이언시스 (SNTI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):